Browse Category

Investment Analysis News 22 December 2025

Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm Incorporated (NASDAQ: QCOM) heads into the Dec. 22, 2025 market open with investors balancing two powerful narratives: a renewed push into data center AI and high-speed connectivity (now backed by a fresh acquisition), and persistent handset-related uncertainty tied to
Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Ahead of the U.S. stock market open on Monday, December 22, 2025, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is stepping into a new spotlight—not just for biotech fundamentals, but also for a major index catalyst that can reshape short-term trading dynamics.
Oracle Stock (ORCL) Before the Market Opens Dec. 22, 2025: Latest News, Analyst Forecasts, and Key Risks Investors Should Watch

Oracle Stock (ORCL) Before the Market Opens Dec. 22, 2025: Latest News, Analyst Forecasts, and Key Risks Investors Should Watch

Oracle Corporation (NYSE: ORCL) heads into the next U.S. session (Monday, Dec. 22, 2025) with investors focused on a familiar tension: massive AI-driven growth ambitions versus the cost and financing pressure of building the infrastructure to deliver them—now compounded by
Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

Date: December 21, 2025 (Sunday) Intuitive Surgical, Inc. (NASDAQ: ISRG) heads into the Christmas-shortened trading week with momentum—yet also with two developments investors will likely keep on the radar: a newly posted FDA Class 2 recall entry tied to a
1 63 64 65 66 67 228
Go toTop